Drug Database
Back to search

Belgium· BE-AMP-SAM253127-00

Ytracis

A diagnostic radiopharmaceuticals product containing yttrium (y-90) chloride, registered in Belgium by Cis Bio International. The same ATC class is registered in 7 of our 19 countries.

ATC V09

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedYtracisATCV09REGISTER NO.BE-AMP-SAM253127-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about yttrium (y-90) chlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Yttrium (y-90) chloride is registered in 7 of 19 countries.

Countries holding a registration under ATC V09 (diagnostic radiopharmaceuticals), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search yttrium (y-90) chloride products by name

Yttrium (y-90) chloride · ATC V09

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Yttrium (Y-90) Chloride
Manufacturer
Cis Bio International
Country
Belgium (BE)
ATC code
V09
ATC class
DIAGNOSTIC RADIOPHARMACEUTICALS
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3335577

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Yttrium (y-90) chloride in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All yttrium (y-90) chloride products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2cfcc848-50e5-4878-ac66-4f53aa06e651
GET /v1/drugs/2cfcc848-50e5-4878-ac66-4f53aa06e651?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Radiopharmaceutical precursor",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Ytracis",
  "name_fr": "Ytracis",
  "name_nl": "Ytracis",
  "amp_code": "SAM253127-00",
  "strengths": [
    "1850.0000",
    "1850.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Yttrium (Y-90) Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Diagnostic Radiopharmaceuticals",
  "authorisation_numbers": [
    "EU/1/03/250/001"
  ]
}
API referenceMCP serverPlans

See everything about yttrium (y-90) chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console